Centerpoint Advisors’s XPeng XPEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-25
Closed -$1K 447
2025
Q1
$1K Hold
25
﹤0.01% 383
2024
Q4
$0 Hold
25
﹤0.01% 496
2024
Q3
$0 Hold
25
﹤0.01% 500
2024
Q2
$0 Hold
25
﹤0.01% 484
2024
Q1
$0 Hold
25
﹤0.01% 464
2023
Q4
$0 Sell
25
-65
-72% -$1.03K ﹤0.01% 618
2023
Q3
$2K Buy
90
+40
+80% +$679 ﹤0.01% 460
2023
Q2
$1K Hold
50
﹤0.01% 551
2023
Q1
$1K Hold
50
﹤0.01% 544
2022
Q4
$0 Hold
50
﹤0.01% 535
2022
Q3
$1K Hold
50
﹤0.01% 376
2022
Q2
$2K Hold
50
﹤0.01% 334
2022
Q1
$1K Hold
50
﹤0.01% 395
2021
Q4
$3K Hold
50
﹤0.01% 318
2021
Q3
$2K Hold
50
﹤0.01% 264
2021
Q2
$2K Hold
50
﹤0.01% 263
2021
Q1
$2K Hold
50
﹤0.01% 238
2020
Q4
$2K Buy
+50
New +$1.84K ﹤0.01% 226

Other funds holding XPEV

Centerpoint Advisors's XPEV Position: Q2 2025 in Review

Centerpoint Advisors sold out of XPeng (XPEV) in Q2 2025, closing a stake of 25 shares — an estimated $1K sold.

Centerpoint Advisors first reported a position in XPEV in Q4 2020 and held it in 18 quarters. The position peaked at $3K in Q4 2021. 216 funds tracked by Wall St. Rank hold XPEV as of Q2 2025.

  • Centerpoint Advisors reported no remaining XPeng position as of Q2 2025 after selling out during the quarter.
  • Centerpoint Advisors sold 25 XPeng shares in Q2 2025, an estimated $1K.
  • Centerpoint Advisors first reported a position in XPeng in Q4 2020 and held it in 18 quarters.
  • Centerpoint Advisors's XPeng position peaked at $3K in Q4 2021.
  • 216 funds tracked by Wall St. Rank held XPeng as of Q2 2025.

Based on Centerpoint Advisors's 13F filing for Q2 2025, filed 1 Aug 2025.